$248.22 Million Smart Inhalers Markets - Global Forecast to 2025 with COVID-19 Impact Assessment
October 16, 2020 01:33 ET
|
Research and Markets
Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Smart Inhalers Market Research Report by Product Type, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19" report has...
Global Smart Inhalers Markets, 2019-2024 with 2018 as the Base Year: Focus on Asthma and COPD with COVID-19 Impact Analysis
October 07, 2020 06:14 ET
|
Research and Markets
Dublin, Oct. 07, 2020 (GLOBE NEWSWIRE) -- The "Smart Inhalers: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report offers a comprehensive picture of the...
Rapid Therapeutic Enters Letter of Intent to Expand Production Capability to 3,000,000 MDI and $100,000,000 in Revenue Annually
September 30, 2020 06:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory
August 18, 2020 07:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
Rapid Therapeutic Science Laboratories (RTSL), Inc. engages Ezzey Digital Marketing Agency to Launch its New Lifestyle Brand “nhāler”
August 06, 2020 07:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Science Files with FDA to Register Facility and Products
August 04, 2020 07:00 ET
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Completes Delivery of Additional 6,000 Units of its Proprietary Metered Dose Inhalers
July 14, 2020 07:30 ET
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 14, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers
July 09, 2020 07:30 ET
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 09, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), a fully-reporting, early stage, emerging biotech company focused on aerosol delivery of...
Rapid Therapeutic Completes Initial Delivery of 2,000 Units of its Proprietary Metered Dose Inhalers
July 08, 2020 07:30 ET
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 08, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol...
Rapid Therapeutic Enters Contract for Certified Lab for Manufacturing Consistent with FDA Rules
June 30, 2020 07:30 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, June 30, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol...